Berenberg Bank reiterated their buy rating on shares of Reckitt Benckiser Group (LON:RKT) in a report issued on Monday, Analyst Ratings Network reports. They currently have a GBX 7,870 ($102.82) target price on the stock.
RKT has been the subject of a number of other reports. JPMorgan Chase & Co. reduced their target price on shares of Reckitt Benckiser Group from GBX 9,000 ($117.59) to GBX 8,500 ($111.05) and set an overweight rating for the company in a report on Wednesday, July 28th. Royal Bank of Canada dropped their price target on shares of Reckitt Benckiser Group from GBX 6,500 ($84.92) to GBX 6,000 ($78.39) and set a sector perform rating on the stock in a research note on Tuesday, July 27th. Deutsche Bank Aktiengesellschaft dropped their price target on shares of Reckitt Benckiser Group from GBX 8,000 ($104.52) to GBX 7,200 ($94.07) and set a buy rating on the stock in a research note on Wednesday, July 28th. Finally, Credit Agricole dropped their price target on shares of Reckitt Benckiser Group from GBX 7,800 ($101.91) to GBX 7,100 ($92.76) and set an outperform rating on the stock in a research note on Wednesday, July 28th. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat, Reckitt Benckiser Group currently has an average rating of Buy and a consensus price target of GBX 7,424.29 ($97.00).
Shares of LON:RKT opened at GBX 5,463 ($71.37) on Monday. The company has a 50-day simple moving average of GBX 5,674.38. Reckitt Benckiser Group has a one year low of GBX 5,050 ($65.98) and a one year high of GBX 6,816 ($89.05). The company has a quick ratio of 0.36, a current ratio of 0.72 and a debt-to-equity ratio of 161.71. The stock has a market capitalization of £39.02 billion and a PE ratio of -24.13.
In related news, insider Pamela Kirby purchased 1,000 shares of the business’s stock in a transaction on Tuesday, August 3rd. The shares were bought at an average price of GBX 5,692 ($74.37) per share, with a total value of £56,920 ($74,366.34). Also, insider Elane Stock purchased 241 shares of the business’s stock in a transaction on Tuesday, July 27th. The shares were bought at an average cost of GBX 5,706 ($74.55) per share, for a total transaction of £13,751.46 ($17,966.37).
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
Recommended Story: What is the S&P/ASX 200 Index?
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.